7.832USD+8.48%Mkt Cap: 8.25B USDP/E: —Last update: 2026-05-26
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against c…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap8.25B USD
Enterprise Value8.85B USD
Revenue (TTM)140.98M USD
Gross Profit112.53M USD
Net Income (TTM)-351.40M USD
Revenue/Share0.1460 USD
Last Price7.832 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees684
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45256X1037
Valuation
P/E (Trailing)—
P/E (Forward)73.71
PEG—
EV/EBITDA-36.07
EV/Revenue62.78
P/S57.50
P/B-9.31
EPS (TTM)-0.85
EPS (Forward)0.10
52W Range
1.95056% of range12.43
52W High12.43 USD
52W Low1.950 USD
Profitability
Gross Margin99.34%
Oper. Margin-157.88%
EBITDA Margin-174.08%
Profit Margin-310.18%
ROE70.21%
ROA-70.01%
Growth
Revenue Growth167.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-304.94M USD
CapEx (TTM)4.25M USD
FCF Margin-137.40%
FCF Yield-2.35%
Net Debt743.73M USD
Net Debt/EBITDA-3.03
Balance Sheet
Debt/Equity-1.04
Current Ratio6.67
Quick Ratio6.24
Book Value/Sh-0.8310 USD
Cash/Share0.3640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)15.25 USD
Target Range12.00 USD – 22.00 USD
# Analysts4
Ownership
Shares Out.1.05B
Float394.04M
Insiders62.48%
Institutions17.56%
Short Interest
Short Ratio9.3d
Short % Float35.56%
Short % Out.13.19%
Shares Short138.11M
Short (prev mo.)135.54M
Technical
SMA 507.747 (+1.1%)
SMA 2004.674 (+67.6%)
Beta0.07
S&P 52W Chg28.31%
Avg Vol (30d)14.04M
Avg Vol (10d)14.92M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—